Scinai Immunotherapeutics (NASDAQ: SCNI) reported Q3 2023 earnings per share (EPS) of -$0.80, up 80% year over year. Total Scinai Immunotherapeutics earnings for the quarter were -$3.11 million. In the same quarter last year, Scinai Immunotherapeutics's earnings per share (EPS) was -$4.00.
As of Q2 2024, Scinai Immunotherapeutics's earnings has grown year over year. Scinai Immunotherapeutics's earnings in the past year totalled -$10.95 million.
What was SCNI's revenue last quarter?
Scinai Immunotherapeutics (NASDAQ: SCNI) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Scinai Immunotherapeutics's revenue was $0.00.
What was SCNI's revenue growth in the past year?
As of Q2 2024, Scinai Immunotherapeutics's revenue has grown null year over year. Scinai Immunotherapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.